scholarly article | Q13442814 |
P356 | DOI | 10.1002/HEP.29848 |
P698 | PubMed publication ID | 29457842 |
P50 | author | Daniel Zamora-Valdés | Q79284703 |
Kymberly Watt | Q89040794 | ||
Julie K Heimbach | Q91078860 | ||
P2093 | author name string | Charles B Rosen | |
Todd A Kellogg | |||
John J Poterucha | |||
Timucin Taner | |||
Nicki M Francisco-Ziller | |||
Sara R Di Cecco | |||
P2860 | cites work | Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. | Q51442516 |
Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. | Q52841922 | ||
Liver denervation attenuates the hypophagia produced by an imbalanced amino acid diet | Q71460779 | ||
Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation | Q73697867 | ||
The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database | Q80757326 | ||
Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation | Q81627107 | ||
Comparable graft and patient survival in lean and obese liver transplant recipients | Q86912829 | ||
Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis | Q88147162 | ||
Prevalence of childhood and adult obesity in the United States, 2011-2012 | Q29547370 | ||
Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes | Q30420533 | ||
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes | Q33746480 | ||
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study | Q33937741 | ||
Morbid obesity in liver transplant recipients adversely affects longterm graft and patient survival in a single-institution analysis | Q35099266 | ||
Current concepts in the pathogenesis of nonalcoholic fatty liver disease | Q36777932 | ||
Liver transplantation at the extremes of the body mass index | Q37566412 | ||
Imaging-based quantification of hepatic fat: methods and clinical applications | Q37597775 | ||
Metabolic syndrome and liver transplantation: a review and guide to management | Q37745416 | ||
State of the art: sleeve gastrectomy. | Q38211178 | ||
Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk | Q38424050 | ||
Health and economic burden of the projected obesity trends in the USA and the UK. | Q39713652 | ||
Sleeve gastrectomy surgery in obese patients post-organ transplantation | Q40045745 | ||
Higher Mortality and Survival Benefit in Obese Patients Awaiting Liver Transplantation | Q40601996 | ||
Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease | Q40813510 | ||
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients | Q41007436 | ||
Postoperative weight gain during the first year after kidney, liver, heart, and lung transplant: a prospective study | Q41250284 | ||
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States | Q41626076 | ||
Bariatric surgery (sleeve gastrectomy) after liver transplantation: case report | Q42554746 | ||
Prolonged waiting times for liver transplantation in obese patients | Q43405937 | ||
Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. | Q43634298 | ||
Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States | Q43851672 | ||
The impact of wait list body mass index changes on the outcome after liver transplantation | Q44997073 | ||
Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease | Q45299361 | ||
Robotic sleeve gastrectomy after liver transplantation | Q45736955 | ||
Weight loss reporting | Q47237824 | ||
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis | Q47394340 | ||
Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation | Q47960515 | ||
Hepatic denervation and dyslipidemia in obese Zucker (fa/fa) rats. | Q48099387 | ||
The autonomic nervous system regulates postprandial hepatic lipid metabolism. | Q51342701 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | gastrectomy | Q827390 |
liver transplantation | Q1368191 | ||
P304 | page(s) | 485-495 | |
P577 | publication date | 2018-05-14 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy | |
P478 | volume | 68 |
Q98612724 | Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge |
Q89798303 | Current management of non-alcoholic steatohepatitis |
Q89896426 | Impact of Having a Planned Additional Operation at Time of Liver Transplant on Graft and Patient Outcomes |
Q92458712 | Management of metabolic syndrome and cardiovascular risk after liver transplantation |
Q92338109 | Minimally Invasive Sleeve Gastrectomy as a Surgical Treatment for Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients |
Q64103989 | Outcomes of Sleeve Gastrectomy in Obese Liver Transplant Candidates |
Q90016994 | Simultaneous liver transplantation and sleeve gastrectomy: first reported case in East Asia |
Search more.